{"schema_version":"secwatch.filing_event.v1","accession":"0001793229-24-000146","form_type":"8-K","ticker":"CTEV","cik":"0001793229","company_name":"Claritev Corp","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.650104+00:00","generated_at":"2026-05-30T05:26:18.195622+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"MultiPlan posts Q3 net loss $391.5M on $361.6M goodwill impairment; revenue down 5.1%","bullets":["Revenue $230.5M (-5.1% YoY); net loss $391.5M vs loss $24.1M in Q3 2023.","Adjusted EBITDA $141.6M (down from $152.3M); Free Cash Flow $41.1M (down from $49.7M).","Recorded $361.6M impairment charge for goodwill and indefinite-lived intangibles.","Identified $6.4B potential medical cost savings in Q3, +10% YoY.","Updated FY2024 guidance: revenues $930-940M (previous $935-955M), Adj. EBITDA $580-590M."],"urls":{"canonical":"https://secwatch.observer/filing/0001793229-24-000146","json":"https://secwatch.observer/filing/0001793229-24-000146.json","markdown":"https://secwatch.observer/filing/0001793229-24-000146.md","text":"https://secwatch.observer/filing/0001793229-24-000146.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1793229/000179322924000146/0001793229-24-000146-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1793229/000179322924000146/mpln-20241105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:26:18.195622+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}